"","pert","cell","type","trend","WTCS","WTCS_Pval","WTCS_FDR","NCS","Tau","TauRefSize","NCSct","N_upset","N_downset","t_gn_sym","MOAss","PCIDss","MOA","Target","Disease.Area","Indication","Phase"
"1","warfarin","HA1E","trt_cp","down",-0.418519867680143,2.52842310954352e-05,0.000677836344179179,-1.46144650166229,-98.9290495314592,2241,-0.335448250255864,100,29,"ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1","Vitamin K antagonist","54678486","vitamin K antagonist","VKORC1","hematology, cardiology","deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), myocardial infarction","Launched"
"2","tetrahydrozoline","HA1E","trt_cp","down",-0.412609395416272,2.55453419156978e-05,0.000677836344179179,-1.44080748382764,-97.2780008924587,2241,0,100,29,NA,NA,"5419","adrenergic receptor agonist","","ophthalmology","eye irritation","Launched"
"3","diloxanide","HA1E","trt_cp","down",-0.401115621217863,2.60675635562232e-05,0.000677836344179179,-1.40067190750178,-98.9290495314592,2241,-0.745675409851319,100,29,NA,"Protein synthesis inhibitor","11367","protein synthesis inhibitor","","infectious disease","amebiasis","Launched"
"4","raloxifene","HA1E","trt_cp","down",-0.392435948713655,2.64592297866172e-05,0.000677836344179179,-1.37036300702554,-97.3226238286479,2241,0,100,29,"ACVRL1; AOX1; BGLAP; EBP; ENG; ESR1; ESR2; PTGR1; RAC1; SERPINB9; SHBG; TFF1","Estrogen receptor antagonist; Selective estrogen receptor modulator (SERM)","5035","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","Launched"
"5","nortriptyline","HA1E","trt_cp","down",-0.39142039734275,2.6502748256661e-05,0.000677836344179179,-1.36681676200139,-89.8259705488621,2241,0,100,29,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ADRB1; ADRB2; ADRB3; CHRM1; CHRM4; CHRM5; HRH1; HTR6; KCNJ10; PGRMC1; PIK3CD; SIGMAR1; SLC6A2; SLC6A4","Tricyclic antidepressant","441358","tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4","neurology/psychiatry","depression","Launched"
"6","etifenin","HA1E","trt_cp","down",-0.389249158310348,2.65897851967485e-05,0.000677836344179179,-1.35923492435587,-92.8157072735386,2241,-0.0267766453960145,100,29,NA,"Compound used in hepatobiliary scans of the liver","170344","renal function diagnostic agent","","","","Preclinical"
"7","IB-MECA","HA1E","trt_cp","down",-0.388327910342683,2.66333036667923e-05,0.000677836344179179,-1.35601798121057,-95.7161981258367,2241,0,100,29,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor agonist","3668","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Phase 3"
"8","bisacodyl","HA1E","trt_cp","down",-0.383493505505138,2.68508960170112e-05,0.000677836344179179,-1.3391365268686,-97.2780008924587,2241,0.0309759521073464,100,29,NA,"Laxative","2391","laxative","","gastroenterology","constipation","Launched"
"9","RS-67506","HA1E","trt_cp","down",-0.380299756902572,2.69814514271425e-05,0.000677836344179179,-1.3279841465807,-96.2516733601071,2241,-0.771151366251851,100,29,"HTR4","Serotonin receptor partial agonist","133076","serotonin receptor partial agonist","HTR4","","","Preclinical"
"10","BRL-37344","HA1E","trt_cp","down",-0.378355415071152,2.70684883672301e-05,0.000677836344179179,-1.32119462047453,-94.8683623382419,2241,-1.04952517988513,100,29,"ADRB1; ADRB2; ADRB3","Adrenergic receptor agonist","9841972","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Phase 2"
"11","RS-67333","HA1E","trt_cp","down",-0.375067985026361,2.71990437773614e-05,0.000677836344179179,-1.30971511015869,-94.6006247211066,2241,-0.0320547651972941,100,29,"HTR4","Serotonin receptor partial agonist","183782","serotonin receptor partial agonist","HTR4","","","Preclinical"
"12","WAY-161503","HA1E","trt_cp","down",-0.373180450669102,2.7286080717449e-05,0.000677836344179179,-1.30312395237573,-95.0022311468095,2241,-1.11331590894797,100,29,NA,"Serotonin receptor agonist","3906894","serotonin receptor agonist","HTR2C","","","Preclinical"
"13","protriptyline","HA1E","trt_cp","down",-0.371535704032016,2.73295991874928e-05,0.000677836344179179,-1.29738059488063,-86.6577420794288,2241,0.0318825997988139,100,29,"SLC6A2; SLC6A4","Tricyclic antidepressant","4976","tricyclic antidepressant","SLC6A2, SLC6A4","neurology/psychiatry","depression","Launched"
"14","DR-2313","HA1E","trt_cp","down",-0.371020741076246,2.73731176575365e-05,0.000677836344179179,-1.29558237484781,-95.5823293172691,2241,0.0238046322866353,100,29,"PARP1; PARP3","PARP inhibitor","135522417","PARP inhibitor","PARP1, PARP3","","","Preclinical"
"15","naringin","HA1E","trt_cp","down",-0.368124016014184,2.75036730676679e-05,0.000677836344179179,-1.28546718310866,-94.6452476572958,2241,0,100,29,"SLCO1A2","Cytochrome P450 inhibitor","442428","cytochrome P450 inhibitor","SLCO1A2","","","Preclinical"
"16","6-benzylaminopurine","HA1E","trt_cp","down",-0.362875883068879,2.77647838879305e-05,0.000677836344179179,-1.26714101480585,-91.8340026773762,2241,-0.871780772435347,100,29,NA,"Purinergic receptor activator","62389","purinergic receptor activator","","","","Preclinical"
"17","RX-821002","HA1E","trt_cp","down",-0.362289327323266,2.78083023579743e-05,0.000677836344179179,-1.26509279700628,-94.2882641677822,2241,-1.03340447500248,100,29,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C","Adrenergic receptor antagonist","108094","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","","","Preclinical"
"18","SC-560","HA1E","trt_cp","down",-0.361944533140121,2.78083023579743e-05,0.000677836344179179,-1.26388879621286,-87.9518072289157,2241,0,100,29,NA,"Cyclooxygenase inhibitor","4306515","cyclooxygenase inhibitor","PTGS1","","","Preclinical"
"19","PAC-1","HA1E","trt_cp","down",-0.358676824088292,2.79388577681057e-05,0.000677836344179179,-1.25247815043225,-90.1383311021865,2241,0.439146034157817,100,29,"CASP3","Caspase activator","135421197","caspase activator","CASP3","","","Phase 1"
"20","nafadotride","HA1E","trt_cp","down",-0.355037809516421,2.83087647634778e-05,0.000677836344179179,-1.23977092784557,-97.0995091477019,2241,-0.881589892469737,100,29,"DRD3","Dopamine receptor antagonist","3408722","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Preclinical"
"21","RU-28318","HA1E","trt_cp","down",-0.354471992352582,2.83958017035653e-05,0.000677836344179179,-1.23779512794088,-94.243641231593,2241,0.0247344388826082,100,29,"NR3C2","Cytochrome P450 inhibitor","3034004","cytochrome P450 inhibitor","NR3C2","","","Phase 2"
"22","MR-16728","HA1E","trt_cp","down",-0.353864600824542,2.83958017035653e-05,0.000677836344179179,-1.23567415282752,-84.6050870147256,2241,-0.0289542014056439,100,29,NA,"Acetylcholine release enhancer; Acetylcholine release stimulant","378811","acetylcholine release enhancer","","","","Preclinical"
"23","pizotifen","HA1E","trt_cp","down",-0.350308746072015,2.9048578754222e-05,0.000677836344179179,-1.22325731938709,-84.1588576528335,2241,0,100,29,"ADRA1B; ADRA1D; ADRA2B; ADRA2C; HTR1B; HTR1D; HTR2B","Serotonin receptor antagonist","27400","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C","neurology/psychiatry","migraine headache","Launched"
"24","ramipril","HA1E","trt_cp","down",-0.349305461276996,2.9440244984616e-05,0.000677836344179179,-1.21975390851682,-96.2070504239179,2241,-0.0218036812159636,100,29,"ACE; BDKRB1","ACE inhibitor","5362129","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","Launched"
"25","tianeptine","HA1E","trt_cp","down",-0.348804488105304,2.9440244984616e-05,0.000677836344179179,-1.21800453997847,-89.6474788041053,2241,0,100,29,"DRD3; GRIA1; OPRM1; SLC6A4","Selective serotonin reuptake enhancer (SSRE)","68870","selective serotonin reuptake enhancer (SSRE)","OPRD1, OPRK1, OPRM1","neurology/psychiatry, pulmonary, gastroenterology","depression, asthma, irritable bowel syndrome","Launched"
"26","aminoglutethimide","HA1E","trt_cp","down",-0.348642364228509,2.9440244984616e-05,0.000677836344179179,-1.21743841303713,-91.4323962516734,2241,-0.0274747697789607,100,29,"CYP11A1; CYP19A1; NR3C1","Glucocorticoid receptor antagonist","2145","glucocorticoid receptor antagonist","CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","Launched"
"27","MRS-1845","HA1E","trt_cp","down",-0.345423036311064,3.03976513255791e-05,0.000677836344179179,-1.20619671130208,-92.4141008478358,2241,0,100,29,"ORAI1","Calcium channel blocker","5202074","calcium channel blocker","","","","Preclinical"
"28","tropicamide","HA1E","trt_cp","down",-0.344858388712417,3.03976513255791e-05,0.000677836344179179,-1.20422499544952,-87.1039714413208,2241,-0.0223440947803358,100,29,"CHRM1; CHRM4","Acetylcholine receptor antagonist","5593","acetylcholine receptor antagonist","CHRM3, CHRM4","ophthalmology","mydriasis diagnostic, cycloplegia diagnostic","Launched"
"29","fluoxetine","HA1E","trt_cp","down",-0.343885013651616,3.07457990859294e-05,0.000677836344179179,-1.20082602759335,-88.2195448460509,2241,-0.0318299879936995,100,29,"ANO1; CHRNA2; CHRNA3; CHRNB4; CKS1B; CYP2C9; HTR2B; KCNH2; SLC6A4","Selective serotonin reuptake inhibitor (SSRI)","3386","selective serotonin reuptake inhibitor (SSRI)","ANO1, HTR2B, SLC6A4","neurology/psychiatry","depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder","Launched"
"30","SC-9","HA1E","trt_cp","down",-0.34247978007808,3.18990385420895e-05,0.000677836344179179,-1.19591903547982,-77.376171352075,2241,0.0265486994146582,100,29,NA,"Protein tyrosine kinase activator","124172","protein tyrosine kinase activator","PRKCA","","","Preclinical"
"31","oxfendazole","HA1E","trt_cp","down",-0.342366797244721,3.18990385420895e-05,0.000677836344179179,-1.19552450614128,-89.6028558679161,2241,0,100,29,NA,"Anthelmintic","40854","anthelmintic agent","","infectious disease","lungworms, tapeworm, gastrointestinal roundworms","Launched"
"32","INCA-6","HA1E","trt_cp","down",-0.340948795900594,3.25082971227024e-05,0.000677836344179179,-1.19057292973175,-90.0044622936189,2241,-0.858342481044829,100,29,"NFATC1","Calcineurin inhibitor","230748","calcineurin inhibitor","NFATC1","","","Preclinical"
"33","moexipril","HA1E","trt_cp","down",-0.338931767458854,3.43795913345848e-05,0.000690536931543785,-1.18352958630274,-78.1347612672914,2241,0,100,29,"ACE; ACE2","ACE inhibitor","91270","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology","hypertension","Launched"
"34","linoleic-acid","HA1E","trt_cp","down",-0.338359933929482,3.52499607354604e-05,0.000694064779588183,-1.18153277760722,-93.8866577420794,2241,0,100,29,"FABP4; FFAR1; FFAR4; HNF4A; KCNB1; PPARG; TRPM8","Oxidative stress inducer","5280450","oxidative stress inducer","FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8","","","Phase 3"
"35","pravastatin","HA1E","trt_cp","down",-0.337859499901151,3.52499607354604e-05,0.000694064779588183,-1.17978529172543,-91.4770191878626,2241,0,100,29,"ABCC2; APOB; CCL2; CETP; CRP; HMGCR; LCAT; SELP; SLCO1B1","HMGCR inhibitor","4889","HMGCR inhibitor","HMGCR, SLCO1B1","endocrinology, cardiology","hypercholesterolemia, myocardial infarction, hyperlipidemia","Launched"
"36","iocetamic-acid","HA1E","trt_cp","down",-0.335476615139733,3.9057826864291e-05,0.000719703885876246,-1.17146439977413,-85.8991521642124,2241,0,100,29,NA,"Radiopaque medium","27648","radiopaque medium","","radiology","contrast agent","Launched"
"37","PCA-4248","HA1E","trt_cp","down",-0.333980400903837,4.07115287259546e-05,0.000734854286775322,-1.16623970859541,-83.3110218652387,2241,-0.914730539966393,100,29,"PTAFR","Platelet activating factor receptor antagonist","4698","platelet activating factor receptor antagonist","PTAFR","","","Phase 1"
"38","nadolol","HA1E","trt_cp","down",-0.333485696382997,4.20388420622898e-05,0.000741626497433624,-1.16451222981323,-86.03302097278,2241,-0.990204259179787,100,29,"ADRB1; ADRB2; ADRB3","Adrenergic receptor antagonist","39147","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, hypertension","Launched"
"39","clebopride","HA1E","trt_cp","down",-0.333050649183959,4.20388420622898e-05,0.000741626497433624,-1.16299307085283,-75.2788933511825,2241,-1.02822985291988,100,29,"ACHE","Dopamine receptor antagonist","2780","dopamine receptor antagonist","ACHE, DRD2","gastroenterology","nausea","Launched"
"40","equilin","HA1E","trt_cp","down",-0.331453278232367,4.57814304860547e-05,0.000776931838780329,-1.15741514643552,-94.020526550647,2241,0.037053827277595,100,29,"HSD17B1","Estrogen receptor agonist","223368","estrogen receptor agonist","HSD17B1","","","Preclinical"
"41","MD-920","HA1E","trt_cp","down",-0.328901509941168,5.02638329005639e-05,0.000820868765024277,-1.14850452323645,-85.4529228023204,2241,0,100,29,NA,NA,"6466","NFkB pathway inhibitor","AADACL2","","","Phase 1"
"42","bendroflumethiazide","HA1E","trt_cp","down",-0.328190877859657,5.31360519234533e-05,0.00085322166393928,-1.14602303824686,-88.6657742079429,2241,-0.840487419467125,100,29,"CA1; CA4; KCNMA1; SLC12A1; SLC12A3","Sodium/potassium/chloride transporter inhibitor","2315","sodium/potassium/chloride transporter inhibitor","SLC12A1, SLC12A3","cardiology","hypertension","Launched"
"43","tomelukast","HA1E","trt_cp","down",-0.328165989247859,5.31360519234533e-05,0.00085322166393928,-1.14593612869381,-89.3351182507809,2241,0.0250886501189012,100,29,"CYSLTR1","Leukotriene receptor antagonist","3969","leukotriene receptor antagonist","CYSLTR1","","","Phase 3"
"44","GW-4064","HA1E","trt_cp","down",-0.32591461710013,5.94027116097573e-05,0.000916077521724164,-1.13807447097257,-88.7550200803213,2241,0,100,29,"NR1H4","FXR agonist","9893571","FXR agonist","NR1H4","","","Preclinical"
"45","BRL-50481","HA1E","trt_cp","down",-0.325892180251365,5.94027116097573e-05,0.000916077521724164,-1.1379961228303,-82.0169567157519,2241,-0.0195534649207653,100,29,"PDE7A; PDE7B","Phosphodiesterase inhibitor","2921148","phosphodiesterase inhibitor","PDE7A, PDE7B","","","Preclinical"
"46","metergoline","HA1E","trt_cp","down",-0.325006038133763,6.28841892132596e-05,0.000946269089549626,-1.13490176722677,-80.0089245872378,2241,0.988575959141308,100,29,"HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR5A; HTR6; HTR7; SCN2A","Dopamine receptor agonist; Serotonin receptor antagonist","28693","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry, endocrinology","seasonal affective disorder, anxiety, hyperprolactinemia","Launched"
"47","BML-190","HA1E","trt_cp","down",-0.3232415524581,7.19577902173874e-05,0.00104023032627564,-1.12874028812609,-86.479250334672,2241,0,100,29,"CNR2","Cannabinoid receptor inverse agonist","2415","cannabinoid receptor inverse agonist","CNR2","","","Preclinical"
"48","AM-251","HA1E","trt_cp","down",-0.322838362207692,7.19577902173874e-05,0.00104023032627564,-1.12733237173677,-78.0008924587238,2241,-0.0251226953564833,100,29,"CNR1; GPR18; GPR55","Cannabinoid receptor antagonist","2125","cannabinoid receptor antagonist","CNR1, GPR18, GPR55","","","Preclinical"
"49","azacyclonol","HA1E","trt_cp","down",-0.322552957330625,7.19577902173874e-05,0.00104023032627564,-1.12633575487014,-85.140562248996,2241,0,100,29,"HRH1","Histamine receptor antagonist","15723","histamine receptor antagonist","HRH1","","","Preclinical"
"50","CO-102862","HA1E","trt_cp","down",-0.320930890895425,8.28591669633538e-05,0.00115076333543907,-1.12067159529195,-84.4265952699688,2241,-0.0231964888887409,100,29,"SCN2A; SCN4A; SCN9A","Sodium channel blocker","10221150","sodium channel blocker","SCN4A, SCN9A","","","Phase 1"
"51","meclizine","HA1E","trt_cp","down",-0.320915116565009,8.28591669633538e-05,0.00115076333543907,-1.12061651226774,-84.8728246318608,2241,0,100,29,"NR1I3",NA,"92303","constitutive androstane receptor (CAR) agonist","NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Launched"
"52","XE-991","HA1E","trt_cp","down",-0.320572469177399,8.28591669633538e-05,0.00115076333543907,-1.11942000795672,-73.0031236055332,2241,0,100,29,"KCNQ1; KCNQ2; KCNQ3; KCNQ4; KCNQ5","Potassium channel blocker","656732","potassium channel blocker","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5","","","Preclinical"
"53","diphenidol","HA1E","trt_cp","down",-0.315764438841915,0.000121808197652535,0.00156582308568389,-1.10263065180828,-76.3052208835341,2241,0,100,29,"CHRM1; CHRM4","Acetylcholine receptor agonist","3055","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","vertigo","Launched"
"54","piperine","HA1E","trt_cp","down",-0.315642951171123,0.000121808197652535,0.00156582308568389,-1.10220642408295,-83.5787594823739,2241,0,100,29,"MAOA; MAOB; NR1I2; TRPV1","Monoamine oxidase inhibitor","638024","monoamine oxidase inhibitor","MAOA, MAOB, TRPV1","","","Phase 1"
"55","doxylamine","HA1E","trt_cp","down",-0.314977567136437,0.000131708649587495,0.00166194472829295,-1.09988294258338,-85.8991521642124,2241,0,100,29,"CHRM1; HRH1; NR1I3","Histamine receptor antagonist","3162","histamine receptor antagonist","HRH1","neurology/psychiatry","sedative","Launched"
"56","PD-98059","HA1E","trt_cp","down",-0.3141703717661,0.000142914655623768,0.00177172536116695,-1.09706426432881,-79.9643016510486,2241,0,100,29,"AKT1; CHEK1; GSK3B; LCK; MAP2K1; MAP2K2; MAPK11; MAPK12; MAPK14; MAPK3; MAPK8; PRKCA; RAF1; ROCK1; RPS6KB1; SGK1","MAP kinase inhibitor; MEK inhibitor","4713","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Preclinical"
"57","GR-135531","HA1E","trt_cp","down",-0.31193735305574,0.000167807220488809,0.00201351139028295,-1.08926669571996,-90.5845604640785,2241,-0.0176596521640082,100,29,NA,"Melatonin receptor agonist","4284525","melatonin receptor agonist","","","","Preclinical"
"58","esculin","HA1E","trt_cp","down",-0.311398269906811,0.000182864611123956,0.00215369709605652,-1.0873842494063,-83.1771530566711,2241,0,100,29,"AR","Antioxidant","15558439","antioxidant","","","","Phase 1"
"59","diethyltoluamide","HA1E","trt_cp","down",-0.310947163690055,0.000182864611123956,0.00215369709605652,-1.08580901331056,-78.0901383311022,2241,0,100,29,NA,"DEET activator of fly antenna ionotropic receptor IR40a","4284","ionotropic receptor IR40a activator","","dermatology","sunscreen lotion","Launched"
"60","E-4031","HA1E","trt_cp","down",-0.308430430009434,0.000240221954641656,0.00270314401261311,-1.07702072888921,-84.694332887104,2241,0,100,29,"KCNH1; KCNH2","Potassium channel blocker","3185","potassium channel blocker","KCNH1, KCNH2","","","Phase 1"
"61","chlortetracycline","HA1E","trt_cp","down",-0.308384980101272,0.000240221954641656,0.00270314401261311,-1.07686202051139,-80.3212851405622,2241,-1.07830580234906,100,29,NA,"Protein synthesis inhibitor","73707519","protein synthesis inhibitor","","ophthalmology","conjunctivitis","Launched"
"62","carteolol","HA1E","trt_cp","down",-0.30778346255648,0.000240221954641656,0.00270314401261311,-1.0747615569984,-70.504239178938,2241,0,100,29,"ADRB1; ADRB2","Adrenergic receptor antagonist","2583","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","Launched"
"63","isoliquiritigenin","HA1E","trt_cp","down",-0.307724309759531,0.000240221954641656,0.00270314401261311,-1.07455499894742,-81.0352521195895,2241,0,100,29,"AKR1B1; HRH2; SIRT1","Guanylate cyclase activator","638278","guanylate cyclase activator","GABBR1","","","Preclinical"
"64","pargyline","HA1E","trt_cp","down",-0.307290332702648,0.000262590448244158,0.00289877651681685,-1.07303957685981,-75.9928603302097,2241,0.0179078537505265,100,29,"MAOA; MAOB; TH","Monoamine oxidase inhibitor","9373","monoamine oxidase inhibitor","MAOA, MAOB","cardiology","hypertension","Launched"
"65","physostigmine","HA1E","trt_cp","down",-0.305975821302991,0.000288462178685184,0.00312433841236303,-1.06844938118506,-68.6746987951807,2241,0,100,29,"ACHE; BCHE; CHRNA4; CHRNB2","Acetylcholinesterase inhibitor; Cholinesterase inhibitor","16212981","acetylcholinesterase inhibitor, cholinesterase inhibitor","ACHE, BCHE","cardiology, neurology/psychiatry, ophthalmology, gastroenterology","hypotension, Alzheimer's disease, glaucoma, gastroparesis","Launched"
"66","bezafibrate","HA1E","trt_cp","down",-0.305601652072765,0.000288462178685184,0.00312433841236303,-1.06714280447324,-83.1771530566711,2241,0,100,29,"APOA1; APOA2; APOB; APOE; CETP; CRAT; HBE1; HBG1; HBG2; HSD11B1; LPL; NR1I2; PPARA; PPARD; PPARG; RXRA; RXRB; RXRG; SERPINE1; UCP3","PPAR receptor agonist","39042","PPAR receptor agonist","PPARA, PPARD, PPARG","cardiology","cholesterol","Launched"
"67","WAY-629","HA1E","trt_cp","down",-0.305167720359965,0.000316770943448662,0.003377616119983,-1.06562754072448,-79.3395805443998,2241,0,100,29,NA,"Serotonin receptor agonist","6604933","serotonin receptor agonist","HTR2C","","","Preclinical"
"68","cilostazol","HA1E","trt_cp","down",-0.304444329145984,0.000347690816414767,0.00364638958447216,-1.06310150160269,-87.9964301651049,2241,0,100,29,"CYP3A5; PDE3A; PDE3B","Phosphodiesterase inhibitor","2754","phosphodiesterase inhibitor","PDE3A, PDE3B","cardiology","claudication","Launched"
"69","methantheline","HA1E","trt_cp","down",-0.304273156547464,0.000347690816414767,0.00364638958447216,-1.06250377706294,-72.3337795626952,2241,0,100,29,"CHRM1; HRH2","Acetylcholine receptor antagonist","4097","acetylcholine receptor antagonist","CHRM1, HRH2","gastroenterology, neurology/psychiatry, urology","peptic ulcer disease (PUD), irritable bowel syndrome, pancreatitis, dyskinesia, neurogenic bladder","Launched"
"70","amodiaquine","HA1E","trt_cp","down",-0.303750881601948,0.000347690816414767,0.00364638958447216,-1.06068002399654,-70.7719767960732,2241,0,100,29,"CYP2C8; HNMT","Histamine receptor agonist","2165","histamine receptor agonist","HNMT","infectious disease","malaria","Launched"
"71","VER-155008","HA1E","trt_cp","down",-0.302622291246007,0.000381069482938344,0.00392391421866784,-1.05673905355554,-76.8853190539938,2241,-0.661020286357656,100,29,"HSPA1A","HSP inhibitor","25195348","HSP inhibitor","HSPA1A","","","Preclinical"
"72","WAY-213613","HA1E","trt_cp","down",-0.302150158924184,0.000416711109904199,0.00422279509741066,-1.05509039555066,-73.4493529674253,2241,0,100,29,"SLC1A2","Glutamate inhibitor","24868316","glutamate inhibitor","SLC1A2","","","Preclinical"
"73","citalopram","HA1E","trt_cp","down",-0.300674804080543,0.000457096250104825,0.00455965167567123,-1.04993854412984,-80.9906291834003,2241,-0.986968037861026,100,29,"SLC6A2; SLC6A4","Serotonin reuptake inhibitor","2771","selective serotonin reuptake inhibitor (SSRI)","ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","depression","Launched"
"74","hyoscyamine","HA1E","trt_cp","down",-0.299884076195302,0.000502137866600136,0.00494032279971651,-1.04717736935442,-58.1436858545292,2241,0,100,29,"CHRM1; CHRM4","Acetylcholine receptor antagonist","154417","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3, CHRM4","gastroenterology, urology, neurology/psychiatry, allergy","peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis","Launched"
"75","bergenin","HA1E","trt_cp","down",-0.297305037260116,0.000660088153624029,0.00623279457323729,-1.03817151868747,-76.5283355644801,2241,0,100,29,"PTPN1","Interleukin inhibitor","66065","interleukin inhibitor","IL1B, TNF","","","Preclinical"
"76","azaperone","HA1E","trt_cp","down",-0.29587256930168,0.000722254288081566,0.00670272981887651,-1.03316942572064,-67.3806336456939,2241,0,100,29,"DRD3","Dopamine receptor antagonist","15443","dopamine receptor antagonist","DRD2, DRD3","neurology/psychiatry","sedative","Launched"
"77","indirubin","HA1E","trt_cp","down",-0.295077356564613,0.000789512083534225,0.00721328375962204,-1.03039259010921,-83.3556448014279,2241,0,100,29,"AHR; CCNE1; CDK1; CDK2; CDK4; CDK5; CDK5R1; CDK9; CYP1A1; GSK3A; GSK3B; LCK; LRRK1; LRRK2","CDK inhibitor; Glycogen synthase kinase inhibitor; Leucine rich repeat kinase inhibitor; Serum/glucocorticoid regulated kinase inhibitor; SRC inhibitor","10177","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A","","","Phase 2/Phase 3"
"78","ZM-241385","HA1E","trt_cp","down",-0.294803207368178,0.000789512083534225,0.00721328375962204,-1.02943527741034,-70.3257474341812,2241,-0.0308830583223099,100,29,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor antagonist","176407","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Preclinical"
"79","NSC-23766","HA1E","trt_cp","down",-0.292095148805274,0.00103167061009283,0.00901701303868887,-1.01997889787216,-72.2445336903168,2241,0,100,29,NA,"Ras GTPase inhibitor","409805","Ras GTPase inhibitor","","","","Preclinical"
"80","thiotepa","HA1E","trt_cp","down",-0.291811832441301,0.00103167061009283,0.00901701303868887,-1.01898957396912,-76.1267291387773,2241,0,100,29,"CYP2B6","Cytochrome P450 inhibitor","5453","cytochrome P450 inhibitor","CYP2B6, CYP3A4","oncology","breast cancer, ovarian cancer, bladder cancer","Launched"
"81","ZD-2079","HA1E","trt_cp","down",-0.290930169459435,0.00112815105817989,0.00972342648719333,-1.01591085924134,-72.3337795626952,2241,0,100,29,"ADRB3","Adrenergic receptor agonist","158794","adrenergic receptor agonist","ADRB3","","","Phase 2"
"82","SB-205384","HA1E","trt_cp","down",-0.290104681410284,0.00122939677873674,0.0104723185104032,-1.01302830403964,-55.1539491298527,2241,-0.0244727475185715,100,29,"GABRA3; GABRA5; GABRA6","GABA receptor modulator","197690","GABA receptor modulator","GABRA3, GABRA5, GABRA6","","","Preclinical"
"83","SCH-28080","HA1E","trt_cp","down",-0.289671900708333,0.00122939677873674,0.0104723185104032,-1.01151705955235,-78.8933511825078,2241,-0.0187899746947725,100,29,"ATP4A","ATPase inhibitor","108137","ATPase inhibitor","ATP4A","","","Phase 1"
"84","AMN-082","HA1E","trt_cp","down",-0.287197937970821,0.00159862923782317,0.0131026583294813,-1.00287812872209,-53.2797858099063,2241,0,100,29,"GRM7","Glutamate receptor modulator; Glutamate receptor positive allosteric modulator","1894361","glutamate receptor modulator","GRM7","","","Preclinical"
"85","phensuximide","HA1E","trt_cp","down",-0.286929252575685,0.00159862923782317,0.0131026583294813,-1.00193989529259,-72.1552878179384,2241,0,100,29,NA,"Succinimide antiepileptic","6839","succinimide antiepileptic","","neurology/psychiatry","seizures","Launched"
"86","RS-79948","HA1E","trt_cp","down",-0.286843497430468,0.00159862923782317,0.0131026583294813,-1.00164044342266,-78.6256135653726,2241,0.0179935992299899,100,29,NA,"Adrenergic receptor antagonist","9908992","adrenergic receptor antagonist","ADRA2A","","","Preclinical"
"87","fipronil","HA1E","trt_cp","down",-0.286647662362039,0.00159862923782317,0.0131026583294813,-1.00095659900389,-77.6885319053994,2241,0,100,29,"GABRB3","Chloride channel blocker; GABA gated chloride channel blocker","3352","chloride channel blocker, GABA gated chloride channel blocker","","infectious disease","flea control","Launched"
"88","L-693403","HA1E","trt_cp","down",-0.285991773285401,0.00174604805509647,0.0141220317529063,-0.998666273333465,-64.2570281124498,2241,0,100,29,"SIGMAR1","Sigma receptor agonist; Sigma receptor antagonist","4687238","sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1","","","Preclinical"
"89","zolantidine","HA1E","trt_cp","down",-0.285176071390876,0.00190314973195451,0.0151842272711287,-0.995817890802042,-70.8165997322624,2241,-0.0298745367240611,100,29,NA,"Histamine receptor antagonist","23640915","histamine receptor antagonist","","","","Preclinical"
"90","talniflumate","HA1E","trt_cp","down",-0.284509333546352,0.00190314973195451,0.0151842272711287,-0.993489681878998,-66.5327978580991,2241,-0.824349416202183,100,29,"CLCA1; CLCNKA","Cyclooxygenase inhibitor","48229","cyclooxygenase inhibitor","CLCA1","neurology/psychiatry","pain relief","Launched"
"91","dicycloverine","HA1E","trt_cp","down",-0.283864032961492,0.00207102223014839,0.016336405356797,-0.991236330592492,-79.5180722891566,2241,0,100,29,"CHRM1","Acetylcholine receptor antagonist","3042","acetylcholine receptor antagonist","CHRM1, CHRM2, CHRM3","gastroenterology","irritable bowel syndrome","Launched"
"92","T-0156","HA1E","trt_cp","down",-0.28293353017139,0.00225214610247059,0.0175244880266066,-0.987987070157334,-58.322177599286,2241,0,100,29,"PDE5A","Phosphodiesterase inhibitor","5368","phosphodiesterase inhibitor","PDE5A","","","Preclinical"
"93","naproxen","HA1E","trt_cp","down",-0.282069797360842,0.00244839264313301,0.0188315200515181,-0.984970966522055,-73.4939759036145,2241,-0.607044773609475,100,29,"AKR1C2; AKR1C3; CYP2C9; LTF; PNLIP; TF","Cyclooxygenase inhibitor","1302","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology, dental, otolaryngology, endocrinology","pain relief, rheumatoid arthritis, headache, toothache, backache, muscle pain, common cold, fever","Launched"
"94","picotamide","HA1E","trt_cp","down",-0.281421299328366,0.00266420073608011,0.0201640331072624,-0.982706449938527,-60.9549308344489,2241,0,100,29,"PPBP; TBXA2R; TBXAS1","Thromboxane receptor antagonist; Thromboxane synthase inhibitor","4814","thromboxane receptor antagonist, thromboxane synthase inhibitor","TBXA2R","hematology","thrombosis","Launched"
"95","PK-11195","HA1E","trt_cp","down",-0.281381504702051,0.00266420073608011,0.0201640331072624,-0.982567489468777,-47.6572958500669,2241,0,100,29,"NR1I2; NR1I3; TSPO","Benzodiazepine receptor antagonist","1345","benzodiazepine receptor antagonist","TSPO","","","Phase 1"
"96","CITCO","HA1E","trt_cp","down",-0.280000297721058,0.00289317316621545,0.0216122669093948,-0.977744396788298,-66.8897813476127,2241,0.0287914202778009,100,29,"NR1I3","CAR agonist","9600409","constitutive androstane receptor (CAR) agonist","NR1I3","","","Preclinical"
"97","RHC-80267","HA1E","trt_cp","down",-0.279271623241387,0.00313813863409187,0.0231264110115982,-0.975199908816749,-66.0865684962071,2241,0,100,29,"DAGLA; DAGLB; LIPC; LIPE; LIPG","Triacylglycerol lipase inhibitor","5063","triacylglycerol lipase inhibitor","DAGLA, DAGLB","","","Preclinical"
"98","indirubin-3-monoxime","HA1E","trt_cp","down",-0.279248183324478,0.00313813863409187,0.0231264110115982,-0.97511805802014,-68.8978134761267,2241,0.0275681270314282,100,29,NA,NA,"3707","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B","","","Preclinical"
"99","lovastatin","HA1E","trt_cp","down",-0.277005309652014,0.00369260746091965,0.0265691981327734,-0.967286076469392,-48.0589022757697,2241,-0.349706696544294,100,29,"APOA1; APOB; CYP2C9; CYP3A5; HDAC2; HMGCR; ITGAL; LDLR; LMNA; NR1I2; RAF1; RASD1; RHOA; RHOB","HMGCR inhibitor","3565209","HMGCR inhibitor","HDAC2, HMGCR, ITGAL, NR1I2","cardiology, endocrinology","coronary heart disease, myocardial infarction, hypercholesterolemia","Launched"
"100","benzoxiquine","HA1E","trt_cp","down",-0.276374786330275,0.00400060943265449,0.0283985182402023,-0.965084326507364,-64.8817492190986,2241,0,100,29,NA,"Anti-infective","6855","antiinfective drug","","","","Preclinical"
"101","atomoxetine","HA1E","trt_cp","down",-0.276110222118437,0.00400060943265449,0.0283985182402023,-0.96416048400498,-50.2454261490406,2241,0,100,29,"GRIN1; GRIN2A; GRIN2B; GRIN2C; GRIN2D; GRIN3A; GRIN3B; SLC6A2; SLC6A3; SLC6A4","Norepinephrine transporter inhibitor","54840","norepinephrine transporter inhibitor","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","attention-deficit/hyperactivity disorder (ADHD)","Launched"
"102","AM-281","HA1E","trt_cp","down",-0.273752107243059,0.00468130358184425,0.032389940892387,-0.955926087023441,-70.3703703703704,2241,-0.0191185217404688,100,29,"CNR1; CNR2; GPR55","Cannabinoid receptor antagonist","4302962","cannabinoid receptor antagonist","CNR1, CNR2, GPR55","","","Preclinical"
"103","ICI-89406","HA1E","trt_cp","down",-0.273560812499234,0.00468130358184425,0.032389940892387,-0.955258097148315,-50.2454261490406,2241,-0.0281333407356238,100,29,"ADRB1; ADRB2","Adrenergic receptor antagonist","123686","adrenergic receptor antagonist","ADRB1, ADRB2","","","Phase 1"
"104","SKF-81297","HA1E","trt_cp","down",-0.273388879627257,0.00506602861626627,0.0346450016501686,-0.954657717778839,-63.9000446229362,2241,0,100,29,"DRD1","Dopamine receptor agonist","11957706","dopamine receptor agonist","DRD1, DRD5","","","Preclinical"
"105","fluvastatin","HA1E","trt_cp","down",-0.27074422893527,0.00591107026757636,0.0394724128475355,-0.945422754757019,-48.8174921909862,2241,-0.941504514070097,100,29,"APOA1; APOB; APOE; CYBA; CYP2C8; CYP2C9; F3; HMGCR; ICAM1; LDLR; RHOA; SELP; SERPINE1","HMGCR inhibitor","1548972","HMGCR inhibitor","HMGCR","endocrinology, cardiology","hypercholesterolemia, congenital heart defects","Launched"
"106","phentolamine","HA1E","trt_cp","down",-0.269834688586263,0.00637667437857474,0.0420560344061109,-0.942246693920183,-63.2753235162874,2241,-0.0282674008176053,100,29,"ADCY10; ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C","Adrenergic receptor antagonist","66148","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","endocrinology, cardiology","pheochromocytoma, hypertension","Launched"
"107","EMD-386088","HA1E","trt_cp","down",-0.268273300498885,0.007416722294151,0.047857749192643,-0.936794419525935,-55.5109326193664,2241,0,100,29,"HTR6","Serotonin receptor agonist","10131112","serotonin receptor agonist","HTR6","","","Preclinical"
"108","trequinsin","HA1E","trt_cp","down",-0.267492058127485,0.00798516054986283,0.050861543760152,-0.934066367601038,-61.0887996430165,2241,-0.903268188601045,100,29,"PDE4A; PDE4B; PDE4C; PDE4D; PDE5A; PTGIR","Phosphodiesterase inhibitor","5537","phosphodiesterase inhibitor","PDE5A","","","Phase 1"
"109","haloperidol","HA1E","trt_cp","down",-0.2666711309625,0.00798516054986283,0.050861543760152,-0.931199738735753,-68.6300758589915,2241,-0.0129039177310302,100,29,"ADCY10; AKR1C1; APITD1-CORT; CYP3A7; DCXR; DRD1; DRD3; DRD4; FOS; GAD1; GRIN1; GRIN2B; HRH1; HTR1D; HTR2B; HTR7; KCNH1; MCHR1; PENK; SLC18A2; TH","Dopamine receptor antagonist; Psychoactive drug","3559","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1","neurology/psychiatry","schizophrenia, Tourette's disorder","Launched"
"110","SJ-172550","HA1E","trt_cp","down",-0.266659078509815,0.00798516054986283,0.050861543760152,-0.931157652287358,-41.4993306559572,2241,0,100,29,"MDM4","MDM inhibitor","1317466","MDM inhibitor","MDM4","","","Preclinical"
"111","cromakalim","HA1E","trt_cp","down",-0.26548313057769,0.00925109108420132,0.0578662232020629,-0.927051312005197,-56.4480142793396,2241,0,100,29,"ABCC9; KCNJ5; KCNJ8","Potassium channel activator","71191","","KCNJ8","","","Phase 2"
"112","calpeptin","HA1E","trt_cp","down",-0.263931301719883,0.00993996670575931,0.0615054678779958,-0.921632417872422,-60.4194556001785,2241,0,100,29,NA,"Calpain inhibitor","2532","calpain inhibitor","","","","Preclinical"
"113","U-18666A","HA1E","trt_cp","down",-0.263729309710956,0.00993996670575931,0.0615054678779958,-0.920927073783391,-41.3654618473896,2241,0.748037332608256,100,29,NA,"Oxidosqualene cyclase inhibitor","415541","oxidosqualene cyclase inhibitor","","","","Preclinical"
"114","L-689560","HA1E","trt_cp","down",-0.262458105248602,0.0114617205662501,0.0695451320758637,-0.916488103359591,-69.2994199018295,2241,0,100,29,"GRIN1; GRIN2A; GRIN2B; GRIN2C; GRIN2D","Glutamate receptor antagonist","4267713","glutamate receptor antagonist","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D","","","Preclinical"
"115","alfadolone-acetate","HA1E","trt_cp","down",-0.262411620419101,0.0114617205662501,0.0695451320758637,-0.916325781097974,-63.9446675591254,2241,0,100,29,NA,NA,"24733","benzodiazepine receptor agonist","","","","Phase 2"
"116","KN-93","HA1E","trt_cp","down",-0.26144533763455,0.0122900293658284,0.0738591067786073,-0.912951579048914,-51.0932619366354,2241,0.0254967512516043,100,29,"CAMK2A","Calcium-calmodulin dependent protein kinase inhibitor","5312122","calcium/calmodulin dependent protein kinase inhibitor","CAMK2A","","","Preclinical"
"117","ondansetron","HA1E","trt_cp","down",-0.260784601936514,0.0122900293658284,0.0738591067786073,-0.910644329264643,-54.5738509593931,2241,-0.911254122634055,100,29,"CYP2D6; CYP3A5; HTR1B; HTR3A; HTR3B; HTR3C; HTR3D; HTR3E; HTR4; OPRM1; SSTR1","Serotonin receptor antagonist","4595","serotonin receptor antagonist","HTR3A, HTR3B","gastroenterology","nausea, vomiting","Launched"
"118","wiskostatin","HA1E","trt_cp","down",-0.259217905043797,0.0141064467869857,0.0831976217328944,-0.9051735168377,-60.6425702811245,2241,0,100,29,"WAS; WASL","Neural Wiskott-Aldrich syndrome protein inhibitor","2775510","actin related protein inhibitor, neural Wiskott-Aldrich syndrome protein inhibitor","WASL","","","Preclinical"
"119","PETCM","HA1E","trt_cp","down",-0.258679181066638,0.0141064467869857,0.0831976217328944,-0.903292324730513,-62.1151271753681,2241,-0.0180658464946103,100,29,"CASP3","Caspase activator","224859","caspase activator","CASP3","","","Preclinical"
"120","zamifenacin","HA1E","trt_cp","down",-0.258148454872915,0.0150961655919563,0.0882308770118203,-0.901439060407707,-58.5006693440428,2241,-0.0180287812081542,100,29,"TNF","Acetylcholine receptor antagonist","3086618","acetylcholine receptor antagonist","CHRM3","","","Phase 3"
"121","NVP-AUY922","HA1E","trt_cp","down",-0.258007500138539,0.0150961655919563,0.0882308770118203,-0.900946854853434,-54.3507362784471,2241,-0.97032693737053,100,29,"HSP90AA1; HSP90AA2; HSP90AB1; HSP90B1; TRAP1","HSP inhibitor","10096043","HSP inhibitor","HSP90AA1, HSP90AB1","","","Phase 2"
"122","PIT","HA1E","trt_cp","down",-0.257921557698391,0.0150961655919563,0.0882308770118203,-0.900646748960742,-42.0348058902276,2241,0,100,29,"P2RY1","Purinergic receptor antagonist","124334","purinergic receptor antagonist","P2RY1","","","Preclinical"
"123","U-54494A","HA1E","trt_cp","down",-0.257874787244636,0.0150961655919563,0.0882308770118203,-0.900483429316207,-68.9870593485051,2241,0,100,29,NA,"Opioid receptor agonist","122015","opioid receptor agonist","OPRK1","","","Preclinical"
"124","flavoxate","HA1E","trt_cp","down",-0.256031465437854,0.0172592511454823,0.099021990716827,-0.894046659131576,-42.7487728692548,2241,0,100,29,"CHRM1","Acetylcholine receptor antagonist","3354","acetylcholine receptor antagonist","CHRM1, CHRM2","urology","urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis","Launched"
"125","benzbromarone","HA1E","trt_cp","down",-0.253849292971338,0.019688430384091,0.110787499293656,-0.886426642583996,-55.1539491298527,2241,0,100,29,"ABCC1; CYP2C9; SLC22A12","Chloride channel blocker","2333","chloride channel blocker","ABCC1","rheumatology","gout","Launched"
"126","proxyfan","HA1E","trt_cp","down",-0.252776404325484,0.0210093900237998,0.117130599045705,-0.88268017920378,-42.9272646140116,2241,0,100,29,"HRH3","Histamine receptor modulator","6421522","histamine receptor modulator","HRH3","","","Preclinical"
"127","UCL-2077","HA1E","trt_cp","down",-0.251540867938002,0.0223870759892107,0.123715784531045,-0.878365759577369,-50.6916555109326,2241,0,100,29,NA,"Slow after hyperpolarization channel blocker","24868317","slow afterhyperpolarization channel blocker","","","","Preclinical"
"128","clomipramine","HA1E","trt_cp","down",-0.24858354472007,0.0269838449429949,0.145156218916104,-0.868038962679798,-47.3449352967425,2241,0,100,29,"HTR2B; SLC6A2; SLC6A3; SLC6A4","Serotonin transporter inhibitor (SERT)","2801","serotonin transporter (SERT) inhibitor","GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","Launched"
"129","HA-1004","HA1E","trt_cp","down",-0.24842661842895,0.0286771268531633,0.152975744824605,-0.8674909853987,-38.9112003569835,2241,-0.686869188014759,100,29,NA,"Calcium channel blocker","3546","calcium channel blocker","","","","Phase 2"
"130","SKF-86002","HA1E","trt_cp","down",-0.247648834594194,0.0286771268531633,0.152975744824605,-0.864775010478193,-41.5439535921464,2241,0,100,29,"ALOX5; MAPK14","p38 MAPK inhibitor","5228","p38 MAPK inhibitor","ALOX5, MAPK14","","","Preclinical"
"131","UK-356618","HA1E","trt_cp","down",-0.246672054153461,0.0304563795009032,0.160861208636192,-0.861364151237713,-50.3792949576082,2241,0,100,29,"MMP13; MMP14; MMP2; MMP3; MMP9","Metalloproteinase inhibitor","10370504","metalloproteinase inhibitor","MMP13, MMP14, MMP2, MMP3, MMP9","","","Preclinical"
"132","loxapine","HA1E","trt_cp","down",-0.246341990844239,0.0323253672338734,0.169563357676051,-0.860211589780443,-30.2989736724676,2241,0,100,29,"ADRA1A; ADRA1B; ADRA2B; ADRA2C; ADRB1; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; HRH1; HRH2; HRH4; HTR1B; HTR1D; HTR1E; HTR3A; HTR5A; HTR6; HTR7; SLC6A2; SLC6A3; SLC6A4","Dopamine receptor antagonist; Dopamine receptor ligand; Serotonin receptor antagonist","3964","dopamine receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","schizophrenia","Launched"
"133","trifluoperazine","HA1E","trt_cp","down",-0.245953787972866,0.0323253672338734,0.169563357676051,-0.858856008427881,-46.7202141900937,2241,0,100,29,"ABCG2; ADCY10; ADRA1A; ANXA7; CALM1; CALM2; CALM3; CALY; CAMK2A; DHCR24; DRD4; EBP; EBPL; HRH1; MYLK3; S100A4; SCN4A; SCN9A; SEC23IP; TNNC1","Dopamine receptor antagonist","5566","dopamine receptor antagonist","ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1","neurology/psychiatry","schizophrenia","Launched"
"134","NNC-711","HA1E","trt_cp","down",-0.244242125159595,0.0363066327065934,0.187535979843116,-0.852878983622952,-44.9352967425257,2241,0,100,29,"SIGMAR1; SLC6A1","GAT inhibitor","4515","GABA uptake inhibitor","SIGMAR1, SLC6A1","","","Preclinical"
"135","kenpaullone","HA1E","trt_cp","down",-0.244038983782171,0.0363066327065934,0.187535979843116,-0.852169626007447,-38.7327086122267,2241,0,100,29,"CCNB1; CDK1; CDK2; CDK5; CDK9; GSK3A; GSK3B; LCK; MAP4K2; MAP4K4; MAP4K5; MINK1; NUAK1","CDK inhibitor; Glycogen synthase kinase inhibitor","3820","CDK inhibitor, glycogen synthase kinase inhibitor","CCNB1, CDK1, CDK5, GSK3B","","","Preclinical"
"136","mefexamide","HA1E","trt_cp","down",-0.243912855240667,0.0363066327065934,0.187535979843116,-0.851729192637431,-39.2235609103079,2241,0,100,29,NA,"Psychoactive drug","4045","psychoactive drug","","","","Preclinical"
"137","gabazine","HA1E","trt_cp","down",-0.242713584699554,0.0384308997848403,0.19669567106717,-0.847541411190947,-37.7510040160643,2241,0.29715649996451,100,29,"GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRG2","GABA receptor antagonist","107895","GABA receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2","","","Preclinical"
"138","toltrazuril","HA1E","trt_cp","down",-0.242139947729596,0.0406627445210355,0.206303498256647,-0.845538304988089,-49.9776885319054,2241,0,100,29,NA,"Antiprotozoal","68591","antiprotozoal agent","","infectious disease","coccidiosis","Launched"
"139","CNQX","HA1E","trt_cp","down",-0.242126030171796,0.0406627445210355,0.206303498256647,-0.845489705703492,-64.301651048639,2241,0.0164347166168795,100,29,"GRIA1; GRIA3; GRIA4","Glutamate receptor antagonist","3721046","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Phase 1"
"140","desmethylclozapine","HA1E","trt_cp","down",-0.240985092113738,0.0429869136914285,0.216707613602818,-0.841505617820629,-43.9535921463632,2241,-0.844623996900937,100,29,"CHRM1; DRD3","Acetylcholine receptor agonist","2820","acetylcholine receptor agonist","HTR2C","","","Phase 2"
"141","exemestane","HA1E","trt_cp","down",-0.240372004917976,0.0454072586806183,0.227511554723778,-0.839364753774135,-47.0771976796073,2241,0,100,29,"CYP19A1","Aromatase inhibitor","60198","aromatase inhibitor","CYP19A1","oncology","breast cancer","Launched"
"142","nomegestrol-acetate","HA1E","trt_cp","down",-0.239793965755304,0.0454072586806183,0.227511554723778,-0.837346275375978,-43.462739848282,2241,-0.0250200921817573,100,29,NA,NA,"91668","progesterone receptor agonist","PGR","endocrinology","contraceptive","Launched"
"143","nimodipine","HA1E","trt_cp","down",-0.23966853437305,0.0454072586806183,0.227511554723778,-0.836908276444627,-38.5988398036591,2241,0,100,29,"AHR; CACNA1C; CACNA1D; CACNA1F; CACNA1S; CACNB1; CACNB2; CACNB3; CACNB4; CFTR; NR3C2","Calcium channel blocker","4497","calcium channel blocker","CFTR, NR3C2","hematology","hemorrhage","Launched"
"144","DMeOB","HA1E","trt_cp","down",-0.239051167481929,0.0479388803977101,0.238583407792632,-0.834752467956318,-36.5015618027666,2241,0,100,29,NA,NA,"6891506","glutamate receptor modulator","GRM5","","","Preclinical"
"145","CGP-13501","HA1E","trt_cp","down",-0.239033243549988,0.0479388803977101,0.238583407792632,-0.834689878651354,-46.0954930834449,2241,0,100,29,"GABBR1","GABA receptor modulator","3519541","GABA receptor modulator","GABBR1","","","Preclinical"
"146","betamethasone-acetate","HA1E","trt_cp","down",-0.238603113143152,0.0479388803977101,0.238583407792632,-0.833187888837076,-45.5153949129853,2241,0,100,29,NA,NA,"443967","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","Launched"
"147","zatebradine","HA1E","trt_cp","down",-0.238136880059834,0.0505539052626407,0.250027472045837,-0.831559830622417,-34.6273984828202,2241,0,100,29,"HCN1; HCN2; HCN3; HCN4","HCN channel blocker","65637","HCN channel blocker","HCN1, HCN2, HCN3, HCN4","","","Phase 3"
"148","mepacrine","HA1E","trt_cp","down",-0.233327350403761,0.0651635561187426,0.31119779538532,-0.8147652389356,-42.7041499330656,2241,0,100,29,"AKT1; MTOR; NFKB1; PLA2G1B; PLA2G2A; PLA2G2D; PLA2G4A; PLA2G6; PLCL1; TP53","Cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator","237","cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B","infectious disease","giardiasis","Launched"
"149","GW-6471","HA1E","trt_cp","down",-0.232354447837775,0.0684082279675016,0.314451408995329,-0.81136792100324,-44.6675591253904,2241,-0.024341037630097,100,29,"PPARA","PPAR receptor antagonist","44634742","PPAR receptor antagonist","PPARA","","","Preclinical"
"150","letrozole","HA1E","trt_cp","down",-0.231736710951011,0.0684082279675016,0.314451408995329,-0.809210820512136,-38.8665774207943,2241,-0.810514273684236,100,29,"CYP19A1","Aromatase inhibitor","3902","aromatase inhibitor","CYP19A1","oncology","breast cancer","Launched"
"151","erythromycin","HA1E","trt_cp","down",-0.229029127135586,0.0787549835719951,0.314451408995329,-0.799756098763934,-37.4386434627398,2241,0,100,29,"ABCB1; ALB; CYP3A4; CYP51A1; KCNH2; MLNR; SLC47A1","NFkB pathway inhibitor","3256","NFkB pathway inhibitor","MLNR","infectious disease","listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma","Launched"
"152","GW-3965","HA1E","trt_cp","down",-0.225310922040428,0.0939448009114856,0.314451408995329,-0.786772347576919,-34.7612672913878,2241,0,100,29,"ABCA1; NR1H2; NR1H3","ABC transporter expression enhancer; LXR agonist","447905","LXR agonist","NR1H2, NR1H3","","","Preclinical"
"153","IRL-2500","HA1E","trt_cp","down",-0.225007668438567,0.0939448009114856,0.314451408995329,-0.785713404024221,-38.3757251227131,2241,-0.0235714021207265,100,29,"EDNRB; HBA2; HBB","Endothelin receptor antagonist","4574540","endothelin receptor antagonist","EDNRB","","","Preclinical"
"154","LFM-A13","HA1E","trt_cp","down",-0.222950151289821,0.102095114055165,0.314451408995329,-0.778528676436943,-37.6617581436859,2241,0,100,29,"BTK","BTK inhibitor","9906875","Bruton's tyrosine kinase (BTK) inhibitor","BTK","","","Preclinical"
"155","simvastatin","HA1E","trt_cp","down",-0.221930108789131,0.106317232500342,0.314451408995329,-0.774966748654533,-28.0232039268184,2241,-0.0387483374327265,100,29,"APOA1; APOE; COG2; CYP2C8; CYP3A4; CYP3A5; HMGCR; ITGAL; ITGB2; LDLR; PON1","HMGCR inhibitor","54454","HMGCR inhibitor","HMGCR, ITGB2","endocrinology, cardiology, neurology/psychiatry","hypercholesterolemia, coronary heart disease, myocardial infarction, stroke, hyperlipidemia","Launched"
"156","altanserin","HA1E","trt_cp","down",-0.219317157137367,0.119505026143938,0.314451408995329,-0.765842476797024,-36.9924141008478,2241,-0.0229752743039106,100,29,NA,"Serotonin receptor antagonist","3033677","serotonin receptor antagonist","HTR2A","","","Phase 2"
"157","digoxigenin","HA1E","trt_cp","down",-0.218679166041325,0.119505026143938,0.314451408995329,-0.763614649811004,-36.0999553770638,2241,-0.02290843949433,100,29,"ATP1A1","Steroid","15478","steroid","","","","Preclinical"
"158","ABT-737","HA1E","trt_cp","down",-0.218551152969007,0.119505026143938,0.314451408995329,-0.763167635771402,-35.6537260151718,2241,-0.0303131496845806,100,29,"BAD; BCL2; BCL2L1; BCL2L2","BCL inhibitor","11228183","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Phase 1/Phase 2"
"159","SR-27897","HA1E","trt_cp","down",-0.217570042041024,0.124057253943633,0.314451408995329,-0.759741654726844,-38.3311021865239,2241,0,100,29,"CCKAR","CCK receptor antagonist","122077","CCK receptor antagonist","CCKAR","","","Phase 2"
"160","anandamide","HA1E","trt_cp","down",-0.217222818629423,0.128673606208937,0.314451408995329,-0.758529171212039,-41.3208389112004,2241,0,100,29,"CACNA1G; CACNA1H; CACNA1I; CNR1; CNR2; FAAH2; GLRA1; GPR119; GPR18; GPR55; KCNA2; KCND3; KCNK3; KCNK9; PLD1; PLD2; PLD3; TRPM8; TRPV1","Cannabinoid receptor agonist","5281969","cannabinoid receptor agonist","CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1","","","Phase 2"
"161","DMP-543","HA1E","trt_cp","down",-0.215691106085498,0.133358826453085,0.314451408995329,-0.753180522051656,-26.9522534582776,2241,0,100,29,NA,"Acetylcholine release stimulant","9887884","acetylcholine release enhancer","","","","Phase 2"
"162","fluocinolone-acetonide","HA1E","trt_cp","down",-0.215289343679277,0.138118354484833,0.314451408995329,-0.751777591609367,-47.1218206157965,2241,-0.0150355518321873,100,29,NA,NA,"6215","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","Launched"
"163","melperone","HA1E","trt_cp","down",-0.211732555356027,0.152643166083584,0.314451408995329,-0.739357498195452,-33.6903168228469,2241,0,100,29,NA,"Dopamine receptor antagonist; Serotonin receptor antagonist","15387","dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A","neurology/psychiatry","psychosis","Launched"
"164","sildenafil","HA1E","trt_cp","down",-0.211066326179,0.157560361532301,0.314451408995329,-0.73703106550907,-36.4123159303882,2241,0,100,29,"C1S; PDE11A; PDE5A; PDE6C; PDE6G; PDE6H; SLCO1B1; SLCO1B3","Phosphodiesterase inhibitor","5212","phosphodiesterase inhibitor","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3","urology","erectile dysfunction","Launched"
"165","CGP-53353","HA1E","trt_cp","down",-0.20939689171226,0.167478438447628,0.314451408995329,-0.731201499580227,-29.6742525658188,2241,-0.737235134442649,100,29,"EGFR; PRKCB","EGFR inhibitor; PKC inhibitor","6711154","EGFR inhibitor, PKC inhibitor","EGFR, PRKCB","","","Preclinical"
"166","atovaquone","HA1E","trt_cp","down",-0.205992153399094,0.182443918074043,0.314451408995329,-0.719312355763871,-36.2338241856314,2241,-0.0143862471152774,100,29,"DHODH","Mitochondrial electron transport inhibitor","44483269","mitochondrial electron transport inhibitor","","infectious disease","pneumonia","Launched"
"167","nitrendipine","HA1E","trt_cp","down",-0.194474645644202,0.239193591435287,0.314451408995329,-0.679093903269473,-31.0129406514949,2241,0,100,29,"CACNA1C; CACNA1D; CACNA1H; CACNA1S; CACNA2D1; CACNA2D2; CACNB2; CACNG1; KCNN4","Calcium channel blocker","4507","calcium channel blocker","CACNA1D, CACNA2D1, KCNN4","cardiology","hypertension","Launched"
"168","probucol","HA1E","trt_cp","down",-0.193626162817282,0.239193591435287,0.314451408995329,-0.676131051670587,-23.9178937974119,2241,0,100,29,"ABCA1; ABCB11; APOA1; APOA2; APOB; APOE; CES1; CETP; SCARB1; SELE; VCAM1","Atherogenesis inhibitor","4912","atherogenesis inhibitor","ABCA1, ABCB11, CES1","cardiology","coronary artery disease (CAD)","Launched"
"169","clemastine","HA1E","trt_cp","down",-0.186368645914459,0.269716053732951,0.314451408995329,-0.650788234023295,-31.9500223114681,2241,0,100,29,"HRH1","Histamine receptor antagonist","26987","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","Launched"
"170","levomepromazine","HA1E","trt_cp","down",-0.183105904978493,0.278941338364417,0.314451408995329,-0.63939493660798,-35.3859883980366,2241,-0.0191818480982393,100,29,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CHRM1; CHRM4; CHRM5; DRD1; DRD3; DRD4; HRH1","Dopamine receptor antagonist","45479743","dopamine receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C","neurology/psychiatry, gastroenterology","psychosis, schizophrenia, bipolar disorder, nausea, insomnia","Launched"
